| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.21 | 0.3 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-12 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-14 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.24 | 0.4 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-12 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.24 | 4e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.25 | 2e-06 |